Client and Community Participation Plan: Ongoing support for the development and delivery of the Bethany CCP Plan 2017-20, and related projects.
Client Quality Consultations: Facilitation of client focus groups to support the implementation of the Bethany Quality Governance Framework.
Strategic Plan: Supporting the development of an inaugural strategic plan for a small private allied health provider working with forensic clients and people with disability.
DHHS Intersex Resources Project: The second phase of a project to develop and update resources relating to the treatment, care and support of people with intersex variations and their families, including Treatment Principles and Guidelines and Future Directions for policy and program best practice.
Healthy Eating and Active Living Initiative: Delivery of multiple workshops to support a review of current HEAL governance arrangements and future planning.
Communications and Engagement Plan: Delivery of multiple workshops to support the development of an integrated communications and stakeholder engagement plan for the Inner East Primary Care Partnership.
Take a Stand and Active Bystander Training: Delivery of sessional training to diverse workplaces and sector leaders to prevent domestic violence and sexual harassment and promote gender equity.
Independent Community Grants Review: Support to undertake a comprehensive review of the Wyndham community grants program and to provide recommendations for future directions.
Wyndham H3 Alliance: Support for the Strategic Partnership Group’s annual planning; development of a client engagement and leadership framework and implementation strategy.
Wyndham Volunteering Strategy: Extensive sector and community consultation to support development of the Wyndham Volunteering Strategy 2019-2024.
Western Region Youth Inclusion Plan: Support for the development of an integrated youth engagement plan and governance structure for the Western Metropolitan Region.
Stakeholder Engagement Project: Support to re-engage stakeholders with the YDHF following the establishment of the supervised injecting facility trial.